[The use of naniprus in patients with myocardial infarct complicated by acute left ventricular failure].

Abstract

A study of 64 patients indicates Naniprus is a highly-effective drug for control left ventricular failure. Intravenous administration of naniprus (15-30 mg 2 times daily) is effective in the prophylaxis of recurrences of left ventricular failure in patients with myocardial infarction.

• Authors: Ia V Malinovskiĭ
• Journal: Likars'ka sprava (Lik Sprava) Issue 1 Pg. 89-91 (Jan 1993) ISSN: 1019-5297 [Print] Ukraine
• Vernacular Title: Primenenie naniprusa u bol'nykh infarktom miokarda, oslozhnennym ostroĭ levozheludochkovoĭ nedostatochnost'iu.
• PMID: 8379148 (Publication Type: English Abstract, Journal Article)

Chemical References

• Nitroprusside

Topics

• Acute Disease
• Aged
• Aged, 80 and over
• Drug Evaluation
• Female
• Heart Failure (drug therapy, etiology, prevention & control)
• Humans
• Infusions, Intravenous
• Male
• Middle Aged
• Myocardial Infarction (complications, drug therapy)
• Nitroprusside (administration & dosage, adverse effects)
• Recurrence
• Time Factors
• Ventricular Function, Left (drug effects)